http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-200231-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c35f3a3c112c482bcfa47356c4f80c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-673
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-67
filingDate 2000-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c65457a14fbb7a70ca091e5b702ea5f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72a5a9601b89a6ba824f3c2154fd9a7b
publicationDate 2008-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-200231-B1
titleOfInvention Pharmaceutical and / or cosmetic agent containing pantothenic acid and / or its derivatives and use of a mixture of pantothenic acid and / or its derivatives
abstract The present invention relates to the use of pantothenic acid and/or its derivatives for treating dermatological disorders which involve the degranulation process of the mastocytes, such as atopic dermatitis, psoriasis, contact eczema, skin allergies, skin inflammation due to insect bites, skin allergies, senile pruritus. The present invention also relates to pharmaceutical and/or cosmetical compositions comprising pantothenic acid and/or its derivatives, glycine and pharmaceutically and/or cosmetically acceptable additives. The inhibition effect on the degranulation process of the mastocytes is strongly increased if the pantothenic acid and/or its derivatives are combined with glycine. A synergic effect in the inhibition by the mixture in comparison with the single compounds is therefore observed.
priorityDate 1999-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490267
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6863
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518226
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100277053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID819276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53442928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414854481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451688804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36511
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID820085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407124392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415721994

Total number of triples: 49.